Lock-up Agreement May 17, 2020Lock-Up Agreement • May 18th, 2020 • Neurotrope, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 18th, 2020 Company Industry JurisdictionThis Lock-up Agreement (this “Agreement”) is executed in connection with the Agreement and Plan of Merger (as amended from time to time, the “Merger Agreement”) by and among Petros Pharmaceuticals, Inc., a Delaware corporation (“Parent”), PM Merger Sub 1, LLC, a Delaware limited liability company and direct wholly owned subsidiary of Parent (“Merger Sub 1”), PN Merger Sub 2, Inc., a Nevada corporation and direct wholly owned subsidiary of Parent (“Merger Sub 2”), Neurotrope, Inc., a Nevada corporation (“Neurotrope”), and Metuchen Pharmaceuticals LLC, a Delaware limited liability company (“Company”), dated as of May 17, 2020. Capitalized terms used herein but not defined shall have the meanings ascribed to such terms in the Merger Agreement.
DropCar, Inc. Form of Lock-Up Agreement December __, 2019Lock-Up Agreement • December 20th, 2019 • DropCar, Inc. • Communications services, nec • New York
Contract Type FiledDecember 20th, 2019 Company Industry JurisdictionThis Lock-Up Agreement (this “Agreement”) is executed in connection with the Agreement and Plan of Merger (the “Merger Agreement”) by and among DropCar, Inc. (“Parent”), ABC Merger Sub, Inc., (“Merger Sub”), and Ayro, Inc. (“Company”), dated as of December 20, 2019. Capitalized terms used herein but not defined shall have the meanings ascribed to such terms in the Merger Agreement.
Alliqua BioMedical, Inc. Lock-Up Agreement October 11, 2018Lock-Up Agreement • October 12th, 2018 • Alliqua BioMedical, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledOctober 12th, 2018 Company Industry JurisdictionThis Lock-Up Agreement (this “Agreement”) is executed in connection with the Agreement and Plan of Merger (the “Merger Agreement”) by and among Alliqua BioMedical, Inc. (the “Parent”), Embark Merger Sub Inc., (“Merger Sub”), and Adynxx, Inc. (the “Company”), dated as of October 11, 2018. Capitalized terms used herein but not defined shall have the meanings ascribed to such terms in the Merger Agreement.
Mast Therapeutics, Inc. Lock-Up Agreement January 6, 2017Lock-Up Agreement • January 9th, 2017 • Mast Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 9th, 2017 Company Industry JurisdictionThis Lock-Up Agreement (this “Agreement”) is executed in connection with the Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) by and among Mast Therapeutics, Inc. (the “Parent”), Victoria Merger Corp., (“Merger Sub”), and Savara Inc. (the “Company”), dated as of January 6, 2017. Capitalized terms used herein but not defined shall have the meanings ascribed to such terms in the Merger Agreement.